Sign In
Buy PAHC
$30.53
-0.540 (-1.74%)
At Close: Jun 23, 2026
Phibro Animal Health Corporation (PAHC) Q4 2025 Earnings Conference Call Transcript
12:29pm, Thursday, 28'th Aug 2025
Phibro Animal Health Corporation (NASDAQ:PAHC ) Q4 2025 Earnings Conference August 28, 2025 9:00 AM ET Company Participants Daniel M. Bendheim - Executive VP of Corporate Strategy & Director Glenn C.
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock
10:41am, Thursday, 28'th Aug 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
PAHC Stock Surges on Q4 Earnings & Revenue Beat, Gross Margin Down
09:15am, Thursday, 28'th Aug 2025
Phibro Animal Health posts strong Q4 earnings and revenues, fueled by Animal Health growth. Meanwhile, the gross margin contracts.
Phibro (PAHC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
07:31pm, Wednesday, 27'th Aug 2025
The headline numbers for Phibro (PAHC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Phibro Animal Health (PAHC) Tops Q4 Earnings and Revenue Estimates
07:21pm, Wednesday, 27'th Aug 2025
Phibro Animal Health (PAHC) came out with quarterly earnings of $0.57 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.41 per share a year ago.
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance
04:57pm, Wednesday, 27'th Aug 2025
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June
Insights Into Phibro (PAHC) Q4: Wall Street Projections for Key Metrics
10:15am, Friday, 22'nd Aug 2025
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Phibro (PAHC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quar
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2025 Results
04:00pm, Wednesday, 20'th Aug 2025
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its fourth quarter and fiscal year 2025 financial results on Wednesday, August 27, 2025, after the m
PAHC vs. BSX: Which Stock Is the Better Value Option?
12:41pm, Wednesday, 20'th Aug 2025
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
10:41am, Wednesday, 20'th Aug 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run?
10:16am, Wednesday, 20'th Aug 2025
Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PAHC Stock Up 76.4% in a Year: What's Driving the Rally?
09:55am, Wednesday, 20'th Aug 2025
Phibro Animal Health's 76.4% stock surge is fueled by strong sales recovery, global growth and a robust balance sheet.
Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why
01:46pm, Monday, 18'th Aug 2025
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
PAHC vs. LMAT: Which Stock Should Value Investors Buy Now?
12:41pm, Monday, 04'th Aug 2025
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the
3 Reasons Growth Investors Will Love Phibro (PAHC)
01:46pm, Friday, 01'st Aug 2025
Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.
